EFFECTS OF ANTICONVULSANTS ON GLIAL ION TRANSPORT
抗惊厥药对胶质离子运输的影响
基本信息
- 批准号:3404324
- 负责人:
- 金额:$ 11.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-04-01 至 1993-11-30
- 项目状态:已结题
- 来源:
- 关键词:NMDA receptors acetazolamide acid base balance adenosinetriphosphatase anions anticonvulsants astrocytes calcium channel blockers carbamazepine carbonate dehydratase cations diazepam drug metabolism electrolyte balance electrophysiology generalized seizures glutamates homeostasis ion transport laboratory mouse membrane permeability membrane potentials neurochemistry phenytoin scintillation counter tissue /cell culture valproate
项目摘要
The six specific aims of this competing renewal are designed to determine
the effects of anticonvulsant and convulsant drugs on ion-transport
processes, acid-base homeostasis and electrophysiology of astrocytes in
tissue culture. These studies are designed to test the hypothesis that
anticonvulsants in addition to their effects on neurons and synapses also
stimulate astrocytic regulatory processes, and in so doing provide the CNS
with an enhanced ability to regulate electrolyte, acid-base and
neurotransmitter homeostasis within the CNS, thereby limiting seizure
activity. Specifically, primary cultures of mouse cerebral cortical
astrocytes will be acutely and chronically exposed to therapeutic
concentrations of the prototype anticonvulsants phenytoin, carbamazepine,
valproate, diazepam, ethosuximide, acetazolamide, and to the calcium
channel blocker flunarizine. The effects of the above treatments on; the
uptake, steady-state distribution and release of 22 Na+, 42 K+, 36 Cl- and
45 Ca++; the intracellular concentration of Na+, K+, Cl- and H+; the
transport enzymes Na+/K+, Ca++/Mg++ -ATPase and the glial specific enzyme
carbonic anhydrase; the electrophysiology (membrane potential, resistance
and conductance); and the uptake of the neurotransmitter substance
glutamate will be assessed. In addition, studies to characterize the effect
of the receptor specific convulsants N-methyl-d-aspartate, and
entylenetetrazol on the above parameters in untreated and
anticonvulsant-treated (acute and chronic) astrocytes will also be
conducted. The focus of this application does not differ significantly from
that of the initial grant. Such an analysis is important for if a thorough
understanding of the mechanisms of these drugs is to be obtained, a
comprehensive examination of their effects on astrocytes as well as neurons
must be undertaken. These studies will also enhance our understanding of
the seizure process. Thus, through an increased understanding of the
mechanisms of the currently available anticonvulsant drugs and the
processes underlying seizure disorders, drugs with greater selectively and
fewer adverse effects can be developed.
该竞争更新的六个具体目标旨在确定
抗惊厥药和抽搐药物对离子传输的影响
过程,酸碱稳态和星形胶质细胞的电生理学
组织培养。这些研究旨在检验以下假设
除了对神经元和突触的影响外,抗惊厥药还
刺激星形胶质细胞调节过程,因此进行中枢神经系统
具有增强的调节电解质,酸碱和
中枢神经系统内的神经递质稳态,从而限制了癫痫发作
活动。具体而言,小鼠脑皮质的一级培养物
星形胶质细胞将急性和长期暴露于治疗中
原型抗惊厥药的浓度,卡马西平,卡马西平,
丙丙酸酯,地西ep,乙糖酰亚胺,乙唑胺和钙
通道阻滞剂氟纳嗪。上述治疗的影响;这
吸收,稳态分布和22 Na+,42 K+,36 Cl-和36 Cl-和
45 Ca ++; Na+,K+,Cl-和H+的细胞内浓度;这
转运酶Na+/K+,Ca ++/mg ++ -ATPase和Glial特异性酶
碳酸酐酶;电生理学(膜电位,电阻
和电导);和神经递质物质的摄取
将评估谷氨酸。此外,研究效果的研究
受体特异性抽搐剂N-甲基-D-天冬氨酸和
在未处理和
抗惊厥药治疗(急性和慢性)星形胶质细胞也将是
实施。该应用程序的重点与
最初的赠款。这样的分析对于彻底的
了解这些药物的机制将得到获得
全面检查其对星形胶质细胞和神经元的影响
必须进行。这些研究还将增强我们对
癫痫发作过程。因此,通过对
当前可用的抗惊厥药的机制和
癫痫发作疾病的基础过程,有选择性更大的药物以及
可以开发出更少的不良影响。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ionic dependence of adenosine uptake into cultured astrocytes.
培养的星形胶质细胞中腺苷摄取的离子依赖性。
- DOI:10.1016/0006-8993(94)91173-8
- 发表时间:1994
- 期刊:
- 影响因子:2.9
- 作者:Bender,AS;Woodbury,DM;White,HS
- 通讯作者:White,HS
Beta-DL-methylene-aspartate, an inhibitor of aspartate aminotransferase, potently inhibits L-glutamate uptake into astrocytes.
Beta-DL-亚甲基-天冬氨酸是一种天冬氨酸转氨酶抑制剂,可有效抑制星形胶质细胞摄取 L-谷氨酸。
- DOI:10.1007/bf00964873
- 发表时间:1989
- 期刊:
- 影响因子:4.4
- 作者:Bender,AS;Woodbury,DM;White,HS
- 通讯作者:White,HS
Pharmacological regulation of astrocytic calcium channels: implications for the treatment of seizure disorders.
星形细胞钙通道的药理学调节:对癫痫症治疗的影响。
- DOI:10.1016/s0079-6123(08)61741-0
- 发表时间:1992
- 期刊:
- 影响因子:0
- 作者:White,HS;Skeen,GA;Edwards,JA
- 通讯作者:Edwards,JA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H Steve WHITE其他文献
H Steve WHITE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H Steve WHITE', 18)}}的其他基金
Development of a galanin-based therapy for the treatment of refractory epilepsy
开发基于甘丙肽的难治性癫痫疗法
- 批准号:
7987135 - 财政年份:2010
- 资助金额:
$ 11.6万 - 项目类别:
Development of a galanin-based therapy for the treatment of refractory epilepsy
开发基于甘丙肽的难治性癫痫疗法
- 批准号:
8550833 - 财政年份:2010
- 资助金额:
$ 11.6万 - 项目类别:
Development of a galanin-based therapy for the treatment of refractory epilepsy
开发基于甘丙肽的难治性癫痫疗法
- 批准号:
8332327 - 财政年份:2010
- 资助金额:
$ 11.6万 - 项目类别:
Development of a galanin-based therapy for the treatment of refractory epilepsy
开发基于甘丙肽的难治性癫痫疗法
- 批准号:
8135222 - 财政年份:2010
- 资助金额:
$ 11.6万 - 项目类别:
Development of a galanin-based therapy for the treatment of refractory epilepsy
开发基于甘丙肽的难治性癫痫疗法
- 批准号:
8730716 - 财政年份:2010
- 资助金额:
$ 11.6万 - 项目类别:
Evaluation of models of pharmacoresistant epilepsy.
耐药性癫痫模型的评估。
- 批准号:
6931486 - 财政年份:2004
- 资助金额:
$ 11.6万 - 项目类别:
相似国自然基金
乙酰唑胺对高原常住居民睡眠呼吸障碍的治疗与作用机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙酰转移酶调控MGMT增强子在胶质母细胞瘤替莫唑胺耐药中作用及分子机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
乙酰唑胺负荷CT灌注成像评价大鼠C6胶质瘤恶性度和侵袭力
- 批准号:81701686
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯酰胺与乙酰唑胺治疗周期性麻痹
- 批准号:
6723860 - 财政年份:2004
- 资助金额:
$ 11.6万 - 项目类别: